NCT01436513View on ClinicalTrials.gov

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Primary Ovarian InsufficiencyVaginitisMetrorrhagiaMenopause
Interventions
DRUG

Premarin reference tablet (fasted)

Premarin reference tablet, single dose, fasted conditions

DRUG

Premarin new tablet (fasted)

Premarin new tablet, single dose, fasted conditions

DRUG

Premarin reference tablet (fed)

Premarin reference tablet, single dose, fed conditions

DRUG

Premarin new tablet (fed)

Premarin new tablet, single dose, fed conditions

Trial Locations (1)

Unknown

Pfizer Investigational Site, Shinjyuku-ku

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY